The impact of genetic variations on the treatment of early rheumatoid arthritis
...the anti-TNF drug etanercept, and 25 milligrams of etanercept twice weekly (the currently approved dose for RA). The results of this clinical trial have been previously published (Bathon et al. New Engl J Med 343:1586-1593, 2000). Researchers examined patients for a particular genetic marker in the HLA reg...NPF says FDA approval of new psoriasis drug signals new era of care
...ecently submitted to the FDA for approval. Amgen's etanercept (brand name Enbrel), has already been approved to treat psoriatic arthritis and recent study results indicate that it is also effective in treating psoriasis. Amgen expects to conclude a second phase III trial of Enbrel this year. If the results are ...New drug blocks rheumatoid arthritis early on, with few side effects
...arge nationwide study concludes that a drug called etanercept dramatically slows or even stops the progress of r...eumatoid arthritis, this study marks a new use for etanercept as an early treatment. The study compared etanercept with the standard therapy, a drug called metho...